Buprenorphine for depression: the un-adoptable orphan.
Callaway
E
E
D000281:Administration, Intranasal; D000286:Administration, Sublingual; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002047:Buprenorphine / Q000008:administration & dosage* / Q000009:adverse effects; D003866:Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D006801:Humans; D008691:Methadone / Q000008:administration & dosage; D009292:Narcotic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D009293:Opioid-Related Disorders / Q000534:rehabilitation; D016896:Treatment Outcome
D000928:Antidepressive Agents; D009292:Narcotic Antagonists; D002047:Buprenorphine; D008691:Methadone